CAS: 84845-57-8; Ritipenem (Fce 22101)

该化合物其结构特征为乙酯环,该环对其抗菌特性至关重要;以及三亚松林环,它能增强抗乙酸盐,某些细菌生成的酶以产生抗药性的抗生素的稳定性;Ritipipenem通常是静脉注射的,用于治疗严重感染,特别是耐多药生物造成的感染;Ritipenem的药性活性能包括人体组织快速分布,其半衰期相对较短,需要小心使用;与其他抗生素一样,存在不利影响的可能性,包括过敏反应和胃肠道扰动.

结构式图片

上下游产品

22891[14C]-FCE22891 (5R,6S)-6-[(R)-1-(tert-Butyl-dimethyl-silanyloxy)-ethyl]-3-carbamoyloxymethyl-7-oxo-4-thia-1-aza-bicyclo[3.2.0]hept-2-ene-2-carboxylic acid acetoxymethyl ester

合成工艺路线路线简述

    📜Acetyloxymethyl (5R,6S)-6-[(1R)-1-[tert-Butyl(Dimethyl)Silyl]Oxyethyl]-3-(Carbamoyloxymethyl)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Hept-2-Ene-2-Carboxylate置于phosphate Buffer,四丁基氟化铵体系中,用 四氢呋喃,溶剂黄146 作为反应溶剂,化学反应生成 利替培南
    参考文献:The Total Synthesis Of Ritipenems. Construction Of Penem Thiazoline Ring By Incorporation Of Two 2C Units Of Glycolic Acid.
    标题:The Total Synthesis Of Ritipenems. Construction Of Penem Thiazoline Ring By Incorporation Of Two 2C Units Of Glycolic Acid.
    摘要:Short Syntheses Of Ritipenem Acoxyl 1A And Ritipenem 1B Are Reported. The Syntheses Start From (R)-4-Acetoxy-(S)-3-[(R)-1-(T-Butyldimethylsilyloxy)Ethyl]Azetidin-2-One 3 And Are Based On The Incorporation Of Two 2C Units Obtained By Manipulation Of Glicolyc Acid 4.
    DOI:10.1016/s0040-4039(00)79192-1

    海关参考信息

    专利信息


    专利号:US-2009111737-A1
    优先权日:1999-05-24
    标题:Novel antibacterial agents
    发明人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    权利人:CHRISTENSEN BURTON G; MORAN EDMUND J; GRIFFIN JOHN H; JUDICE J KEVIN; MU YONGQI; PACE JOHN L; MAMMEN MATHAI; AGGEN JAMES
    摘要:This invention relates to novel multibinding compounds (agents) that are antibacterial agents. The multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands in their monovalent (i.e., unlinked) state have the ability to bind to a an enzyme involved in cell wall biosynthesis and metabolism, a precursor used in the synthesis of the bacterial cell wall and/or the bacterial cell surface thereby interfere with the synthesis and/or metabolism of the cell wall. In particular the multibinding compounds of the invention comprise from 2-10 ligands covalently connected by a linker or linkers, wherein each of said ligands hasn a ligand domain capable of binding to penicillin binding proteins, a transpeptidase enzyme, a substrate of a transpeptidase enzyme, a beta-lactamase enzyme, pencillinase enzyme, cephalosporinase enzyme, a transglycoslase enzyme, or a transglycosylase enzyme substrate; Preferably, the ligands are selected from the beta lactam or glycopeptide class of antibacterial agents.

    专利号:US-2014315720-A1
    优先权日:2012-10-24
    标 题 :Polysaccharide ester microspheres and methods and articles relating thereto
    发明人:FALLON DENIS G; GARRETT THOMAS S; KIZER LAWTON E; ZAZZARA KAREN L; COMBS MICHAEL T; JOHNSON RICHARD K; DEHART GARY
    权利人:CELANESE ACETATE LLC
    摘要:A method for producing a polysaccharide ester microsphere may include forming a polysaccharide ester product from a polysaccharide synthesis, wherein the polysaccharide ester product comprises a polysaccharide ester and a solvent; diluting the polysaccharide ester product, thereby yielding a polysaccharide ester dope; and forming a plurality of polysaccharide ester microspheres from the polysaccharide ester dope. Suitable polysaccharides may include, but are not limited to, starch, cellulose, hemicellulose, algenates, chitosan, and any combination thereof. Esters thereof may be organic esters (e.g., acetate and the like), inorganic esters (e.g., sulfonates and the like), or combinations thereof. Further, the solids conent of the polysaccharide ester dope, in some instances, may be greater than about 16 wt %.

    专利号:US-4508649-A
    优先权日:1981-12-11
    标题 :Process for preparing optically active penems
    发明人:ALPEGIANI MARCO; BATTISTINI CARLO; BEDESCHI ANGELO; FRANCESCHI GIOVANNI; FOGLIO MAURIZIO; ZARINI FRANCO
    权利人:ERBA FARMITALIA
    摘要:Processes for the preparation of a penem derivative of formula I ##STR1## wherein n=0 or 1; R is a carboxy protecting group or H; n R 1 is hydrogen, a hydrocarbon group substituted or unsubstituted, or lower alkoxy; and n R 2 is hydrogen, C 1 -C 5 alkyl, carbamoyl N-substituted by lower alkyl or unsubstituted, or an acyl group; n and the pharmaceutically acceptable salts thereof. n These processes allow one to prepare stereospecifically only 5R derivatives, and are characterized by R 2 -introduction at a very late stage in the synthesis, thereby enabling a great number of compounds of formula I to be prepared. n Penem derivatives are useful antibacterial agents.

    专利号:NZ-505979-A
    优先权日:1998-06-08
    标 题 :Multibinding antibacterial agents comprising 2 antibiotic or aglycone ligands, connected by a linker, capable of affecting cell wall synthesis or metabolism

    专利号:CN-102268024-A
    优先权日:2011-06-10
    标 题 :New crystal form of biapenem and its synthesis method

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献

    1. Lovering AM, White LO, Lewis DA, MacGowan AP, Routh KR, Pickin DM, Reeves DS. Pharmacokinetics of FCE 22101 in man following different modes of administration. J Antimicrob Chemother. 1989 Mar;23 Suppl C:179-95. doi: 10.1093/jac/23.suppl_c.179.

    合成参考文献


    参考文献:10.2165/00002018-199615020-00001
    摘要:Norrby SR. Neurotoxicity of carbapenem antibacterials. Drug Saf. 1996 Aug;15(2):87–90. doi: 10.2165/00002018-199615020-00001.
    参考文献:10.1093/jac/29.2.179
    摘要:Lovering AM, MacGowan AP, Lewis DA, Reeves DS. Pharmacokinetics and metabolism of FCE 22101 following its administration as the oral pro-drug FCE 22891. J Antimicrob Chemother. 1992 Feb;29(2):179–85. doi: 10.1093/jac/29.2.179.
    参考文献:10.1093/jac/16.3.305
    摘要:Neu HC, Chin NX, Labthavikul P. The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics. J Antimicrob Chemother. 1985 Sep;16(3):305–13. doi: 10.1093/jac/16.3.305.
    摘要:Jannuzzo MG, Vaiani R, Strolin Benedetti M, Carnovali M, Cassinelli G, Corigli R. Pharmacokinetics and metabolism of FCE 22101, a new penem antibiotic. J Chemother. 1989 Jul;1(4 Suppl):511–2.
    摘要:Hitzenberger G, Strolin Benedetti M, Jannuzzo MG, Silvestri S, Moro E, Frigerio E, Sassella D. Pharmacokinetics and clinical tolerability of FCE 22101, a new penem antibiotic, in healthy volunteers after a single i.m. administration. J Chemother. 1989 Jul;1(4 Suppl):513–4.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知